covid pill

New Delhi: Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. Amid rising cases of new Covid variant Omicron in the country, an expert panel of the Central…

Seoul: South Korea on Monday approved an emergency authorization of US drug giant Pfizer Inc.'s oral drug to treat Covid-19, making it the first such pill to be used in the country. Paxlovid is the antiviral pill for the treatment of…

Wellington: New Zealand's medicine regulator on Tuesday approved a new Covid-19 medicine Ronapreve, which can both prevent and treat the disease though it is not a substitute for vaccination and its effectiveness against the Omicron variant…

New York: While oral anti-viral pills against Covid can turn out as a game changer, vaccines and booster shots continue to be pivotal in the fight against the deadly infectious disease, Pfizer CEO Albert Bourla has said. The US drug…

Hyderabad: Anti-viral drug Molnupiravir may emerge as the game changer in the fight against Covid-19 as studies suggest it can reduce the risk of hospitalisation or death in newly-diagnosed patients, an expert says. Distinguished…

New Delhi: Countries in Asia Pacific are rushing to place orders for the latest weapon against Covid 19 -- an antiviral pill that isn't even authorized for use yet, CNN reported. Molnupiravir -- produced by US pharmaceutical company…

Washington: Merck on Friday announced its anti-viral drug has shown "compelling results" in clinical trials -- halving the risk of hospitalisation or death for patients with mild or moderate cases of Covid. Molnupiravir, co-developed…

New York: US-based pharmaceutical major Pfizer's Chief Executive Officer Albert Bourla said that the company's Covid-19 oral antiviral pill, which is in early-stage trials, could be ready by the end of the year, the media reported.…